| Term Name: | beta-D-GlcA-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer |
|---|---|
| Synonyms: | (2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl beta-D-glucopyranuronosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside, (Gal)2 (Glc)1 (GlcA)1 (GlcNAc)1 (Cer)1, beta-D-GlcpA-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer, beta-D-GlcUA-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer, IV3GlcA-nLc4-Cer |
| Definition: | A glycopentaosylceramide having β-D-GlcA-(1→3)-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc as the pentasaccharide component; isolated from human sciatic nerves and cauda equina. |
| Ontology: | ChEBI [CHEBI:60324] ( EBI ) |